Assessing the BD landscape for in-licensing & acquisition deals

Challenge: A private equity client assessing a major investment asked Alacrita to research and assess the business development landscape for potential in-licensing or acquisition deals that could be...
Learn More

Scouting in-licensing targets in inflammation and fibrosis

Challenge: A pharmaceutical company with marketed therapeutics in several respiratory disorders wanted to supplement its internal pipeline with external innovation. The company had already searched...
Learn More

New in-licensing opportunities in inflammation

Challenge A small molecule pharmaceutical incubator is using a novel and proprietary drug discovery and translational platform to develop first-in-class, small molecule therapeutics for the treatment...
Learn More

Sourcing licensing opportunities in oncology & other therapeutic areas

Alacrita provides both in- and out-licensing support to a number of pharmaceutical and biotech organizations and companies. Below you'll find a series of case studies related to this service. 
Learn More

Screening for rare disease licensing opportunities

Challenge Our client, a commercial stage biotech company focused on rare and ultra-rare diseases was seeking to build its pipeline of development products. Whilst it had an established business...
Learn More

Searching and assessing stem cell medicines

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....
Learn More

Providing search and assessment support for oncology projects

Challenge A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Searching for late stage therapeutics, devices and diagnostics acquisition targets in the US

Challenge A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was...
Learn More

Scouting medtech technology for M&A opportunities

Challenge A rapidly growing European-headquartered specialty medtech company wanted to conduct a search for M&A opportunities in the interventional medicine arena. 
Learn More

Scouting for early-stage oncology opportunities

Challenge A listed North American company needed support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Life Science Technology Scouting

Life science scouting Since 2013, Rob Johnson, based in Boston, MA, has been engaged by a well-capitalized Swiss pharma company to scout and identify early stage in-licensing opportunities from the...
Learn More
1